Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
TP-008 is an inhibitor of activin receptor-like kinase 4 (ALK4) and ALK5, also known as TGF-β receptor type 1 (TGF-βRI; IC50s = 113 and 343 nM, respectively).1 It is selective for ALK4 and ALK5 over a panel of 467 kinases at 1 µM. TP-008 inhibits ALK4 or ALK5 signaling in a reporter assay using HEK293 cells expressing ALK4 or ALK5 (IC50s = 526 and 245 nM, respectively). It inhibits TGF-β1-induced increases in the levels of phosphorylated Smad2 in C2C12 mouse skeletal muscle myoblasts when used at concentrations of 1 or 10 µM. In vivo, TP-008 (150 or 500 mg/kg per day) induces valvular interstitial cell proliferation, neutrophil infiltration, hemorrhage, and fibrin deposition in rat heart valves.2
WARNING This product is not for human or veterinary use.
1. A highly selective chemical probe for activin receptor-
2. Design, synthesis and optimization of novel Alk5 (activin-